Brain Tumours & Metastases Flashcards

1
Q

Primary Brain Tumours

A

Primary brain tumours originate within the brain or surrounding structures, as opposed to metastatic tumours which spread from other sites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classification of Primary Brain Tumours is completed by ___

A

Histology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name some examples of Gliomas

A

Gliomas (tumours of glial cells):
Astrocytomas (including glioblastoma multiforme).
Oligodendrogliomas.
Ependymomas.
Meningiomas (arise from meninges).
Medulloblastomas (common in children, cerebellum).
Pituitary tumours (e.g., prolactinomas).
Schwannomas (e.g., vestibular schwannomas).
Craniopharyngiomas (near the pituitary).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Meningiomas arise from __

A

Meninges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epidemiology of Glioblastoma multiforme

A

Most common primary malignant brain tumour in adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Epidemiology of Meningiomas

A

Most common primary benign tumour in adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Epidemiology of Medulloblastomas

A

Most common malignant brain tumour in children.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes and risk factors of Primary Brain Tumours

A

Genetic syndromes: Neurofibromatosis type 1 and 2, Li-Fraumeni syndrome, tuberous sclerosis, and von Hippel-Lindau disease.
Ionising radiation.
Family history of brain tumours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

General Symptoms of Primary Brain Tumours

A

(due to raised intracranial pressure):

Headache (worse in the morning or with straining).
Nausea and vomiting.
Papilloedema (optic disc swelling).
Seizures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Focal Neurological Symptoms of Primary Brain Tumours depend on what?

A

Depend on tumour location

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Focal Neurological Symptoms: Frontal Lobe

A

Personality changes, poor decision-making, hemiparesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Focal Neurological Symptoms: Temporal Lobe

A

Seizures, memory impairment, language disturbances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Focal Neurological Symptoms: Parietal Lobe

A

Sensory loss, visuospatial issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Focal Neurological Symptoms: Occipital Lobe

A

Visual field defects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Focal Neurological Symptoms: Cerebellum

A

Ataxia, balance issues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Focal Neurological Symptoms: Brainstem

A

Cranial nerve palsies, ataxia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Dx/ Ix for Primary Brain Tumours

A

Neuroimaging:

MRI (with contrast): Gold standard for characterising brain tumours.
CT scan: Quicker but less detailed.
Biopsy:

Essential for definitive diagnosis and histopathological classification.
Other Tests:

Blood tests: Check endocrine function if a pituitary tumour is suspected.
Lumbar puncture: Rarely used but may assist in medulloblastoma or other paediatric cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Name some examples of Primary Brain Tumours

A

Glioblastoma Multiforme (GBM), Meningiomas, Vestibular Schwannomas (Acoustic Neuromas), Medulloblastomas, Pituitary Tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Features of Glioblastoma Multiforme (GBM)

A

Highly aggressive, poor prognosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Imaging of Glioblastoma Multiforme (GBM)

A

“Ring-enhancing lesion” on contrast MRI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Tx for Glioblastoma Multiforme (GBM)

A

Surgery, radiotherapy, temozolomide (chemotherapy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Features of Meningiomas

A

Typically slow-growing and benign.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Sx for Meningiomas

A

Often incidental findings; may cause focal deficits.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Tx for Meningiomas

A

Surgical resection if symptomatic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Features of Vestibular Schwannomas (Acoustic Neuromas)

A

Affects CN VIII, leading to hearing loss and tinnitus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Symptoms of Vestibular Schwannomas (Acoustic Neuromas)

A

Balance problems, facial numbness (compression of CN VII).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Tx for Vestibular Schwannomas (Acoustic Neuromas)

A

Surgery or stereotactic radiosurgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Features of Medulloblastomas

A

Common in children; arises in the posterior fossa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Sx for Medullablastomas

A

Ataxia, hydrocephalus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Tx for Medulloblastomas

A

Surgery, craniospinal radiotherapy, and chemotherapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Features of Pituitary Tumours

A

Hormonal dysfunction (e.g., prolactinoma causing amenorrhoea, galactorrhoea).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Tx for Pituitary Tumours

A

Medical therapy (e.g., dopamine agonists for prolactinomas) or surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Management for Primary Brain Tumours

A

Surgical Resection, Radiotherapy:
Post-surgery or for non-operable tumours.
Chemotherapy:
Typically adjunctive (e.g., temozolomide for GBM).
Symptom Control

34
Q

Surgical Resection is the primary tx for ____

A

Primary treatment for accessible tumours.

35
Q

What is used for symptom control in Primary Brain Tumours

A

Corticosteroids: To reduce cerebral oedema.
Antiepileptics: For seizure control.
Rehabilitation: Occupational and physiotherapy for functional impairments.

36
Q

Prognosis of a Primary Brain Tumours depends on ___

A

Dependent on tumour type, grade, and location.

37
Q

Prognosis of Glioblastomas

A

Poor prognosis (median survival ~12-18 months).

38
Q

Prognosis of Meningiomas

A

Excellent prognosis if benign and resectable.

39
Q

What are Brain Metastases?

A

Brain metastases refer to secondary tumours that have spread to the brain from a primary cancer elsewhere in the body. These are the most common type of brain tumour in adults.

40
Q

Name some common primary cancers (Brain Metastases)

A

Lung cancer (most common cause).
Breast cancer.
Melanoma (high propensity to metastasize to the brain).
Kidney cancer.
Colorectal cancer.

41
Q

Epidemiology of Brain Metastases

A

Occurs in approximately 10-30% of adult cancer patients.
Most common in patients with advanced or late-stage cancer.

42
Q

Pathophysiology of Brain Metastases

A

Tumour cells spread via the bloodstream or lymphatic system to the brain

43
Q

Common locations of Brain Metastases include:

A

Cerebral hemispheres (~80%).
Cerebellum (~15%).
Brainstem (~5%).

44
Q

Symptoms of Brain Metastases

A

Raised Intracranial Pressure:

Headaches (worse in the morning).
Nausea and vomiting.
Blurred vision due to papilloedema Memory impairment, confusion, or personality changes.

45
Q

Are seizures common in Brain Metastases

A

Common presentation in metastases involving the cerebral cortex.

46
Q

Dx/ Ix for Brain Metastases

A

Imaging:

MRI with contrast: Gold standard for identifying and characterizing brain metastases.
CT scan with contrast: Quicker, used in emergency settings.
2. Biopsy:

Rarely required but may be necessary if there is diagnostic uncertainty.

47
Q

Ix to identify a primary tumour

A

Chest X-ray or CT thorax, abdomen, and pelvis.
Mammography or breast MRI.
Colonoscopy if colorectal cancer is suspected.
PET-CT scan for metastatic workup.

48
Q

Differential Dx for Brain Metastases

A

Primary brain tumours (e.g., glioblastoma).
Abscesses or infections (e.g., toxoplasmosis in immunocompromised patients).
Stroke or haemorrhage.
Autoimmune conditions (e.g., multiple sclerosis).

49
Q

Symptomatic Tx for Brain Metastases

A

Corticosteroids (e.g., dexamethasone): Reduce cerebral oedema and pressure.
Antiepileptic drugs: For seizure control (e.g., levetiracetam).
Analgesics: For headache and pain relief.

50
Q

Definitive Tx for Brain Metastases

A

Surgical resection: For accessible and symptomatic metastases in selected patients.
Radiotherapy:
Whole brain radiotherapy (WBRT): For multiple metastases.
Stereotactic radiosurgery (SRS): For small, isolated lesions.
Systemic Therapy:
Chemotherapy, immunotherapy, or targeted therapy depending on the primary cancer type.

51
Q

Palliative care for Brain Metastases

A

For patients with poor prognosis or extensive disease.

52
Q

Prognosis of Brain Metastases

A

Poor overall prognosis, dependent on factors such as:
Number and size of metastases.
Control of primary tumour.
Performance status of the patient.

53
Q

Median survival for Brain Metastases without tx

A

~1 month.

54
Q

Median survival for Brain Metastases with tx

A

(e.g., surgery + radiotherapy): 3-12 months.

55
Q

What is Metastatic Disease ?

A

Metastatic disease refers to the spread of cancer cells from a primary tumour to distant sites in the body, forming secondary tumours.

56
Q

Common sites of Metastatic

A

Bone: Common in breast, prostate, and lung cancers.
Liver: Frequently seen in colorectal and pancreatic cancers.
Lung: Commonly affected in metastatic breast, colorectal, and kidney cancers.
Brain: Seen in melanoma, lung, and breast cancers.
Peritoneum: Often involved in ovarian and gastric cancers.

57
Q

Mechanism of Spread in Metastatic Disease

A

Hematogenous Spread: Via the bloodstream; common in sarcomas and carcinomas.
Lymphatic Spread: Via the lymphatic system; common in carcinomas.
Direct Invasion: Into surrounding tissues.
Transcoelomic Spread: Across body cavities (e.g., pleural or peritoneal).

58
Q

Symptoms of Bone Metastases

A

Bone pain (worse at night).
Pathological fractures.
Hypercalcaemia (confusion, constipation, polyuria).

59
Q

Symptoms of Liver Metastases

A

Jaundice.
Hepatomegaly.
Right upper quadrant pain.
Elevated liver enzymes.

60
Q

Symptoms of Lung Metastases

A

Cough, haemoptysis.
Dyspnoea.
Chest pain.

61
Q

Symptoms of Brain Metastases

A

Headaches, seizures.
Focal neurological deficits.
Cognitive and personality changes.

62
Q

Symptoms of Peritoneal Metastases

A

Ascites (fluid accumulation in the abdomen).
Abdominal pain and bloating.

63
Q

Ix for Metastatic Disease

A

General Workup:

Full blood count.
Liver function tests.
Tumour markers (e.g., CA-125 for ovarian cancer, PSA for prostate cancer).
Imaging:

CT scan of the chest, abdomen, and pelvis: Commonly used for staging.
MRI: Particularly for brain and spinal metastases.
Bone scan: For suspected bone metastases.
PET-CT: Highly sensitive for detecting metastases across the body.
Biopsy:

Required to confirm the metastatic nature of the disease and often to identify the primary tumour if unknown.

64
Q

Differential Dx for Metastatic Disease

A

Primary tumours at the site of metastasis.
Benign conditions (e.g., cysts, abscesses).
Inflammatory or autoimmune diseases (e.g., sarcoidosis).

65
Q

Management of Metastatic Disease

A

Systemic Therapy:

Chemotherapy: Targets rapidly dividing cells across the body.
Hormonal Therapy: For hormone-sensitive cancers (e.g., tamoxifen for breast cancer).
Targeted Therapy: Focuses on specific molecular pathways (e.g., trastuzumab for HER2-positive breast cancer).
Immunotherapy: Enhances the immune response to cancer cells (e.g., checkpoint inhibitors like pembrolizumab).
2. Local Treatments:

Surgery: For resectable metastases (e.g., liver metastases in colorectal cancer).
Radiotherapy: To control symptoms like pain or prevent complications (e.g., spinal cord compression).
3. Supportive and Palliative Care:

Symptom Management: Pain relief, antiemetics, bisphosphonates for bone metastases.
Psychological Support: Counselling and therapy for patients and families.
End-of-Life Care: Ensuring comfort and dignity in advanced stages.

66
Q

Prognosis of Metastatic Disease

A

Heavily dependent on:
Type and aggressiveness of the primary tumour.
Extent of metastatic spread.
Patient’s overall health and response to treatment.

67
Q

Median Survival for Metastatic Disease

A

Varies widely; for example:
Brain metastases: ~6-12 months with treatment.
Bone metastases: Prognosis depends on cancer type (e.g., prostate cancer metastases can be indolent).

68
Q

What is an Acoustic Neuroma?

A

(Vestibular Schwannoma):
A benign, slow-growing tumour arising from the Schwann cells of the vestibulocochlear nerve (cranial nerve VIII).

69
Q

Epidemiology of Acoustic Neuroma

A

Typically occurs in adults aged 40-60 years.
Accounts for 8% of all intracranial tumours and 90% of cerebellopontine angle tumours

70
Q

Neurofibromatosis Type 2 (NF2) is associated with ___

A

bilateral acoustic neuromas.

71
Q

Acoustic Neuroma originates from ___

A

the vestibular division of cranial nerve VIII

72
Q

What does an Acoustic Neuroma compress?

A

Compresses adjacent structures:
Cochlear nerve: Hearing impairment.
Facial nerve: Facial weakness or paresthesia.
Trigeminal nerve: Sensory loss in the face.
Brainstem and cerebellum: Ataxia and other neurological symptoms in advanced cases.

73
Q

Early symptoms of Acoustic Neuroma

A

Unilateral hearing loss: The most common presenting feature, typically sensorineural.
Tinnitus: Persistent ringing in one ear.
Vertigo or imbalance.

74
Q

Later symptoms of Acoustic Neuroma

A

from nerve/brainstem compression):

Facial numbness or weakness (trigeminal or facial nerve involvement).
Ataxia: Due to cerebellar involvement.
Headaches and papilledema: From raised intracranial pressure in large tumours.

75
Q

Bilateral tumours are indicative of ___

A

NF2.

76
Q

Dx for Acoustic Neuroma

A

Audiometry:

Shows sensorineural hearing loss.
2. Imaging:

MRI with contrast: Gold standard for detecting tumours in the cerebellopontine angle.
CT scan: May be used if MRI is unavailable.
3. Vestibular Testing:

May show impaired vestibular function.
4. Genetic Testing:

For NF2 if bilateral tumours or family history are present.

77
Q

Differential Dx for Acoustic Neuroma

A

Ménière’s disease.
Presbycusis (age-related hearing loss).
Chronic otitis media.
Brainstem tumours.
Multiple sclerosis (if presenting with vertigo or sensory symptoms).

78
Q

Conservative managment for Acoustic Neuroma

A

Observation and serial MRIs: For small, asymptomatic tumours or elderly patients.

79
Q

Surgical resection of Acoustic Neuroma

A

Recommended for large tumours or significant symptoms.
Risks include damage to the facial nerve, resulting in permanent weakness.

80
Q

Stereotactic Radiosurgery for Acoustic Neuroma

A

(e.g., Gamma Knife):

Used for small to medium-sized tumours.
Aims to halt growth while preserving function.

81
Q

Complications of Acoustic Neuroma

A

Facial nerve damage:

Can occur during surgery, leading to weakness or paralysis.
Hearing loss:

Permanent hearing loss may result from tumour or treatment.
Hydrocephalus:

From compression of the brainstem or blockage of cerebrospinal fluid flow.
Cerebellar dysfunction:

Imbalance and ataxia.

82
Q

Prognosis for Acoustic Neuroma

A

Excellent prognosis with early detection and treatment.
Growth rate is usually slow, allowing for careful monitoring in many cases.